The present prophylactic trends of rubella and measles.
Starting from the epidemiological investigation on a sample of 22.560 subjects of different chronological age classes in the Latium region with the research of hemoagglutinoinhibiting antibodies of the Rubella virus, and of 9.800 subjects with the research of hemoagglutinoinhibiting antibodies of the Measles virus, the authors observe that the diffusion of the seroprotection presents on an average 82.5% for Rubella and 79.8% for Measles. On the strength of the results, referred also according to the established chronological age classes, any obligatory treatment against Rubella is excluded in prepuberal age. In order to prevent the risk of congenital malformation in cases of pregnant and not seroprotected subjects who, during the first three months of gestation might come into contact with sick affected by Rosolia or with healthy carriers, the authors suggest the vaccination three months before the conception. Evidently, this involves a screening of the adult female population before their marriage. On the contrary as concerns Measles, the vaccination within the second year of life is being hypothesized exactly on the basis of the consideration that this is a matter of a serious illness and not always free from grave complications. In these cases, after shortly referring on the results of the experiments of different authors, the mixed anti-Measles and anti-Rubella vaccination might be taken into consideration, though with all the precautions that are suggested.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D000906:Antibodies / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D004198:Disease Susceptibility; D005260:Female; D005777:Geese / Q000276:immunology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007106:Immune Sera; D007223:Infant; D007231:Infant, Newborn; D007558:Italy; D008253:Macaca mulatta / Q000276:immunology; D008457:Measles / Q000276:immunology / Q000517:prevention & control*; D011247:Pregnancy; D012409:Rubella / Q000276:immunology / Q000517:prevention & control*; D014611:Vaccination / Q000639:trends
D000906:Antibodies; D007106:Immune Sera